Stay updated on Biomarker Response to Immunotherapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:44:41.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, indicating a minor maintenance update. No substantive changes to study details, eligibility criteria, or outcomes are apparent from the provided context.
    Difference
    0.1%
    Check dated 2026-02-11T14:06:47.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1; this change does not alter any study details, eligibility criteria, outcomes, or locations.
    Difference
    0.1%
    Check dated 2026-02-04T10:17:02.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle label and minor UI text tweaks. Updated the revision string from v3.3.4 to v3.4.0 and corrected capitalization of QC-related fields (No FEAR Act data).
    Difference
    0.2%
    Check dated 2026-01-28T05:55:45.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    New revision entries appear for 2026-01-08, 2025-12-16, and 2025-12 with version v3.3.4, while older revisions including 2025-09-18, 2025-09-16, 2025-03 and v3.3.3 were removed.
    Difference
    0.3%
    Check dated 2026-01-14T03:17:51.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a Locations section highlighting Massachusetts study sites (Boston) and updated the page revision to v3.3.3. The previous Massachusetts Locations grouping and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T20:44:56.000Z thumbnail image

Stay in the know with updates to Biomarker Response to Immunotherapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.